Autoimmune Diseases

Here you'll find selected publications pertaining to the enumeration of immune cells in the respective disease indication

  • CCR6+ cells
    • Elevated levels of CCR6 + T helper 22 cells correlate with skin and renal impairment in systemic lupus erythematosus (Zhong, 2017)
  • CXCR3+ cells
    • CXCR3, inflammation, and autoimmune diseases (Lacotte, 2009)
    • Chemokines and their receptors in rheumatoid arthritis: Future targets? (Koch, 2005)
  • memory B-cells
    • The ISCCA flow protocol for the monitoring of anti-CD20 therapies in autoimmune disorders (Gatti, 2020)
    • Memory B cell subsets and plasmablasts are lower in early than in long-standing Rheumatoid Arthritis (Fedele, 2014)
    • Alterations in peripheral blood memory B cells in patients with active rheumatoid arthritis are dependent on the action of tumour necrosis factor (Souto-Carneiro, 2009)
  • Th17 cells
    • Quantifying circulating Th17 cells by qPCR: potential as diagnostic biomarker for rheumatoid arthritis (Burska, 2019)
    • Circulating Th17 and Th1 cells expressing CD161 are associated with disease activity in rheumatoid arthritis (Miao, 2014)
  • Th17/Treg Balance
    • Propionic Acid Shapes the Multiple Sclerosis Disease Course by an Immunomodulatory Mechanism (Duscha, 2020)
    • The Balance of Th17 versus Treg Cells in Autoimmunity (Lee, 2018)
  • Treg
    • Simultaneous quantification of natural and inducible regulatory T-cell subsets during interferon-β therapy of multiple sclerosis patients (Chiarini, 2020)
    • Regulatory T cells in patients with early untreated rheumatoid arthritis: Phenotypic changes in the course of methotrexate treatment (Avdeeva, 2020)